Clopidogrel Acyl-β-D-glucuronide from Santa Cruz Biotechnology, Inc. | Biocompare.com

Supplier Images

Clopidogrel Acyl-β-D-glucuronide Chemicals

Be the first to write a review!

Citations:

Supplier Page from
Santa Cruz Biotechnology, Inc. for
Clopidogrel Acyl-β-D-glucuronide

Description

Clopidogrel Acyl- beta -D-glucuronide

Product Specs
ItemClopidogrel Acyl-β-D-glucuronide
CompanySanta Cruz Biotechnology, Inc.
Price $970.00Supplier Page View Company Product Page
Catalog Numbersc-217936
Quantity1 mg
TypeBiochemical Reagents
Molecular Weight483.92

Add to Compare List

Santa Cruz Biotechnology, Inc.

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Critical Differences between Enzyme Sources in Sensitivity to Detect Time-Dependent Inactivation of CYP2C8Drug metabolism and disposition: the biological fate of chemicalsApril 1, 2019Kahma H, Filppula AM, Launiainen T, Viinamäki J, Neuvonen M, Evangelista EA, Totah RA, Backman JT.

(2) Clopidogrel Carboxylic Acid Glucuronidation is Mediated Mainly by UGT2B7, UGT2B4, and UGT2B17: Implications for Pharmacogenetics and Drug-Drug Interactions( )Drug metabolism and disposition: the biological fate of chemicalsFebruary 1, 2018Kahma H, Filppula AM, Neuvonen M, Tarkiainen EK, Tornio A, Holmberg MT, Itkonen MK, Finel M, Neuvonen PJ, Niemi M, et al.

(3) A long-standing mystery solved: the formation of 3-hydroxydesloratadine is catalyzed by CYP2C8 but prior glucuronidation of desloratadine by UDP-glucuronosyltransferase 2B10 is an obligatory requirementDrug metabolism and disposition: the biological fate of chemicalsApril 1, 2015Kazmi F, Barbara JE, Yerino P, Parkinson A.

(4) Glucuronidation converts clopidogrel to a strong time-dependent inhibitor of CYP2C8: a phase II metabolite as a perpetrator of drug-drug interactionsClinical pharmacology and therapeuticsOctober 1, 2014Tornio A, Filppula AM, Kailari O, Neuvonen M, Nyrönen TH, Tapaninen T, Neuvonen PJ, Niemi M, Backman JT.

Be the First to Write a Review!